Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
C LindleyEric Winer

Abstract

To evaluate the quality of life (QOL) of breast cancer patients who survived 2 to 5 years following initiation of adjuvant cytotoxic and/or hormonal therapy and to characterize relationships between QOL and patient physical symptoms, sexual function, and preferences regarding adjuvant treatment. Eighty-six patients who had completed systemic adjuvant therapy for early-stage breast cancer between 1988 and 1991 were surveyed by written questionnaire and telephone interview. Sociodemographic information was obtained for each patient, and patients were asked to complete the Functional Living Index-Cancer (FLIC), the Symptom Distress Scale (SDS), the Medical Outcomes Study (MOS) Short Form 36 (SF-36), a series of questions regarding sexual function, and a survey about preferences for adjuvant therapy in relation to possible benefit. The mean FLIC score among all patients was 138.3 (+/- 12.2), which suggests a high level of QOL. The reported frequency of moderate to severe symptoms was generally low (ie, < 15%), with fatigue (31.4%), insomnia (23.3%), and local numbness at the site of surgery (22.1%) occurring with greatest frequency. Patients reported a wide range of sexual difficulties. Preference assessment showed that more than 6...Continue Reading

Associated Clinical Trials

Citations

Nov 5, 1999·Current Opinion in Oncology·A C Wolff
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A B Kornblith
Oct 12, 2001·Current Oncology Reports·S E Soule, K D Miller
Jan 5, 2002·Journal of the National Cancer Institute. Monographs·R J Simes, A S Coates
Feb 13, 2002·Cancer Nursing·Megan Rogers, Linda J Kristjanson
Jul 26, 2002·Psychosomatic Medicine·Julienne E BowerJohn L Fahey
Oct 2, 2002·Breast Cancer Research and Treatment·Jo A BroeckelCharles E Cox
Feb 6, 2003·Journal of the National Cancer Institute·Kelly-Anne Phillips, Jürg Bernhard
Jul 9, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aron GoldhirschHans-Jörg Senn
Jun 24, 2004·International Journal of Technology Assessment in Health Care·Laura Sampietro-ColomAngela B Hutchinson
Aug 23, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Nancy K JanzSteven J Katz
Jan 10, 2006·Cancer·Julienne E BowerThomas R Belin
Apr 25, 2006·Journal of Palliative Medicine·Elizabeth A Kvale, John L Shuster
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie R BurwellNancy E Avis
Apr 13, 2007·Psycho-oncology·Wayne A BardwellUNKNOWN Women's Healthy Eating & Living (WHEL) Study Group
Jun 8, 2007·The New England Journal of Medicine·Rinaa S PungliaJay R Harris
May 15, 2007·Acta Oncologica·Patricia A Ganz, Julienne E Bower
Aug 1, 2007·The Oncologist·Joseph A RoscoeGary R Morrow
Sep 2, 2008·Journal of Experimental & Clinical Cancer Research : CR·Ali Montazeri
Jun 24, 2009·The Pharmacogenomics Journal·H Landmark-HøyvikV Dumeaux
Sep 19, 2009·Expert Opinion on Pharmacotherapy·Gerald M Higa
Oct 28, 2009·Journal of Cancer Survivorship : Research and Practice·Olivia S FuDawn L Hershman
Jan 29, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Julienne E BowerBeth Sternlieb
Sep 2, 2011·Journal of the National Cancer Institute·Jennifer J Griggs, Daniel F Hayes
Feb 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel F Hayes
Mar 13, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Seunghoon LeeJae-dong Lee
Dec 10, 2015·Behavioral Sleep Medicine·Gregory S Vander WalCynthia K Perkins
Sep 18, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A GoldhirschH J Senn
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M Stiggelbout, J C de Haes
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Savard, C M Morin
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C K Daugherty
Oct 24, 2002·American Journal of Clinical Oncology·Alistair Ring, Peter Harper
Aug 7, 2003·Journal of the National Cancer Institute·Julienne E BowerSteve W Cole
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J T JansenA M Stiggelbout
Oct 1, 2005·Journal of Advanced Nursing·Joanna E SmithKaren Pilkington
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter NieboerElisabeth G E de Vries
Jul 13, 2002·Cancer·Nadége CarelleDavid Khayat
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julienne E Bower
Jun 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ruud KnolsGeert Aufdemkampe
Nov 1, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Helen G Mar FanIan F Tannock
Feb 7, 2009·The Cancer Journal·Patricia Fobair, David Spiegel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Treatment and Research
Amelia B Zelnak, Ruth O'Regan
Annals of Oncology : Official Journal of the European Society for Medical Oncology
P L Bedard, F Cardoso
The American Journal of Nursing
C J Brown-Daniels, A Blasdell
© 2022 Meta ULC. All rights reserved